Considerable variation among Iranian dermatologists in the knowledge and attitudes regarding the use of biologic agents to manage psoriasis,

• Egile Nagusiak: Mina Almasi-Nasrabadi, MD (Egilea), Reza M. Robati, MD (Egilea), Omid Zargari, MD (Egilea), Mohammad Shahidi-Dadras, MD (Egilea)
• Formatua: Liburua
• Argitaratua: Wolters Kluwer, 2019-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Many international guidelines have been introduced with the aim of helping clinicians by providing evidence-based advice for the prescription of biologic therapies in psoriasis. Because no local or regional guideline is available, the treatment of psoriasis with biologics is mainly based...